ATE203545T1 - Substrate und inhibitoren von proteolytischen enzymen - Google Patents

Substrate und inhibitoren von proteolytischen enzymen

Info

Publication number
ATE203545T1
ATE203545T1 AT97918252T AT97918252T ATE203545T1 AT E203545 T1 ATE203545 T1 AT E203545T1 AT 97918252 T AT97918252 T AT 97918252T AT 97918252 T AT97918252 T AT 97918252T AT E203545 T1 ATE203545 T1 AT E203545T1
Authority
AT
Austria
Prior art keywords
inhibitors
proteolytic enzymes
substrates
proteases
indentification
Prior art date
Application number
AT97918252T
Other languages
German (de)
English (en)
Inventor
Martin Quibell
Tony Johnson
Terance Hart
Original Assignee
Medivir Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9608457.9A external-priority patent/GB9608457D0/en
Priority claimed from GBGB9616115.3A external-priority patent/GB9616115D0/en
Priority claimed from GBGB9624584.0A external-priority patent/GB9624584D0/en
Application filed by Medivir Uk Ltd filed Critical Medivir Uk Ltd
Application granted granted Critical
Publication of ATE203545T1 publication Critical patent/ATE203545T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047Simultaneous synthesis of different peptide species; Peptide libraries
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043Leu-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00279Features relating to reactor vessels
    • B01J2219/00306Reactor vessels in a multiple arrangement
    • B01J2219/00313Reactor vessels in a multiple arrangement the reactor vessels being formed by arrays of wells in blocks
    • B01J2219/00315Microtiter plates
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00497Features relating to the solid phase supports
    • B01J2219/00504Pins
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B60/00Apparatus specially adapted for use in combinatorial chemistry or with libraries
    • C40B60/14Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
AT97918252T 1996-04-24 1997-04-24 Substrate und inhibitoren von proteolytischen enzymen ATE203545T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9608457.9A GB9608457D0 (en) 1996-04-24 1996-04-24 Inhibitors of proteolytic enzymes
GBGB9616115.3A GB9616115D0 (en) 1996-07-31 1996-07-31 Substrate and inhibitors of proteolytic enzymes
GBGB9624584.0A GB9624584D0 (en) 1996-11-27 1996-11-27 Substances and inhibitors of proteolytic enzymes
PCT/GB1997/001157 WO1997040065A2 (en) 1996-04-24 1997-04-24 Substrates and inhibitors of proteolytic enzymes

Publications (1)

Publication Number Publication Date
ATE203545T1 true ATE203545T1 (de) 2001-08-15

Family

ID=27268257

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97918252T ATE203545T1 (de) 1996-04-24 1997-04-24 Substrate und inhibitoren von proteolytischen enzymen

Country Status (10)

Country Link
US (2) US6528275B1 (OSRAM)
EP (2) EP0906334A1 (OSRAM)
JP (2) JP4215822B2 (OSRAM)
AT (1) ATE203545T1 (OSRAM)
AU (2) AU728263B2 (OSRAM)
CA (2) CA2252408A1 (OSRAM)
DE (1) DE69705838T2 (OSRAM)
DK (1) DK0906333T3 (OSRAM)
ES (1) ES2162277T3 (OSRAM)
WO (2) WO1997040065A2 (OSRAM)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6042789A (en) * 1996-10-23 2000-03-28 Glaxo Group Limited System for parallel synthesis of organic compounds
US6149869A (en) * 1996-10-23 2000-11-21 Glaxo Wellcome Inc. Chemical synthesizers
CA2270394A1 (en) * 1996-10-31 1998-05-07 Novalon Pharmaceutical Corporation Identification of drugs using complementary combinatorial libraries
US6617114B1 (en) 1996-10-31 2003-09-09 Karo Bio Ab Identification of drug complementary combinatorial libraries
US6054325A (en) * 1996-12-02 2000-04-25 Glaxo Wellcom Inc. Method and apparatus for transferring and combining distinct chemical compositions with reagents
US6083761A (en) * 1996-12-02 2000-07-04 Glaxo Wellcome Inc. Method and apparatus for transferring and combining reagents
GB9722818D0 (en) * 1997-10-30 1997-12-24 Peptide Therapeutics Ltd A method for mapping the active sites bound by enzymes that covalently modify substrate molecules
EP1034154A1 (en) * 1997-11-26 2000-09-13 Peptide Therapeutics Limited A solid-phase technology for the preparation of combinatorial libraries through amide-bond anchoring
US6083682A (en) 1997-12-19 2000-07-04 Glaxo Group Limited System and method for solid-phase parallel synthesis of a combinatorial collection of compounds
MY153569A (en) 1998-01-20 2015-02-27 Mitsubishi Tanabe Pharma Corp Inhibitors of ?4 mediated cell adhesion
US6569636B2 (en) * 1998-05-29 2003-05-27 Hawaii Biotechnology Group, Inc. Assay for modulators of metallo-enzyme activity
DE19925402C2 (de) * 1999-06-02 2001-12-20 Molecular Machines & Ind Gmbh Screening von Target-Ligand-Wechselwirkungen
AU2001262906A1 (en) * 2000-02-11 2001-08-20 Cellomics, Inc. Peptide biosensors for anthrax protease
JP2002250730A (ja) * 2001-02-27 2002-09-06 Shinwa Kako Kk 分子センサー及びその製造方法
MY140707A (en) 2002-02-28 2010-01-15 Mitsubishi Tanabe Pharma Corp Process for preparing a phenylalanine derivative and intermediates thereof
JP2005535710A (ja) * 2002-08-09 2005-11-24 トランス テック ファーマ,インコーポレイテッド アリールおよびヘテロアリール化合物ならびに凝固を調節する方法
US7208601B2 (en) 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
WO2005014532A1 (en) * 2003-08-08 2005-02-17 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions and methods of use
US8015064B2 (en) * 2005-04-20 2011-09-06 At&T Intellectual Property I, Lp System and method of providing advertisements to cellular devices
JP2009502158A (ja) * 2005-07-26 2009-01-29 カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ 酵母のストレス耐性を増加させる遺伝子類の同定方法類、およびそれらの遺伝子類の酵母株改良のための使用
EP2364366B1 (en) 2008-11-05 2014-01-08 MorphoSys AG Deconvolution method
EP2189536A1 (en) * 2008-11-20 2010-05-26 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Rapid FRET based anthrax diagnosis
JP5798487B2 (ja) * 2008-11-20 2015-10-21 ネーデルランドセ・オルガニサティ・フォール・トゥーヘパスト−ナトゥールウェテンスハッペライク・オンデルズーク・テーエヌオー Fretに基づく病原体の迅速診断
EP3608317A1 (en) * 2012-01-12 2020-02-12 Yale University Compounds & methods for the enhanced degradation of targeted proteins & other polypeptides by an e3 ubiquitin ligase
GB201311891D0 (en) 2013-07-03 2013-08-14 Glaxosmithkline Ip Dev Ltd Novel compound
GB201311888D0 (en) 2013-07-03 2013-08-14 Glaxosmithkline Ip Dev Ltd Novel compounds
US20180228907A1 (en) 2014-04-14 2018-08-16 Arvinas, Inc. Cereblon ligands and bifunctional compounds comprising the same
RU2018120330A (ru) 2015-11-02 2019-12-04 Йейл Юниверсити Химерные соединения, осуществляющие нацеливание для протеолиза, и способы их получения и применения

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0428000A1 (en) 1989-11-03 1991-05-22 Abbott Laboratories Fluorogenic substrates for the detection of proteolytic enzyme activity
US5011910A (en) * 1989-12-28 1991-04-30 Washington University Reagent and method for determining activity of retroviral protease
US5164300A (en) 1989-12-28 1992-11-17 Washington University Method for determining activity of retroviral protease
DK93990D0 (da) * 1990-04-17 1990-04-17 Carlsberg As Fluorogene peptider og deres anvendelse ved bestemmelse af enzymatisk aktivitet
HU9201687D0 (en) 1992-05-21 1992-08-28 Arpad Furka Preparation of sets from peptid mixtures with polycomponents and their use for the identification of biologically active peptides
US5585275A (en) 1992-09-02 1996-12-17 Arris Pharmaceutical Corporation Pilot apparatus for peptide synthesis and screening
EP0734530B1 (en) 1993-12-15 1997-11-12 Combichem, Inc. Combinatorial libraries and methods for their use
US5506115A (en) 1994-04-29 1996-04-09 G. D. Searle & Co. Reagent and method for determining activity of herpes protease
US5738996A (en) 1994-06-15 1998-04-14 Pence, Inc. Combinational library composition and method
JP2000503533A (ja) 1996-01-04 2000-03-28 ネーデルランドセ・オルガニザテイエ・フール・テゲパスト―ナトウールベテンシヤツペリーク・オンデルツエク・テイエヌオー 蛍光消光基質を用いたタンパク質分解酵素のアッセイ方法
US7135288B2 (en) * 2002-09-27 2006-11-14 Ut-Battelle, Llc Combinatorial synthesis of ceramic materials

Also Published As

Publication number Publication date
EP0906334A1 (en) 1999-04-07
DK0906333T3 (da) 2001-11-12
JP2001501170A (ja) 2001-01-30
AU706855B2 (en) 1999-06-24
CA2252508A1 (en) 1997-10-30
DE69705838D1 (de) 2001-08-30
ES2162277T3 (es) 2001-12-16
WO1997040065A2 (en) 1997-10-30
WO1997042216A1 (en) 1997-11-13
US20030092067A1 (en) 2003-05-15
US6528275B1 (en) 2003-03-04
WO1997040065A3 (en) 1997-12-04
DE69705838T2 (de) 2002-04-11
JP4215822B2 (ja) 2009-01-28
JP2000512979A (ja) 2000-10-03
EP0906333A2 (en) 1999-04-07
CA2252408A1 (en) 1997-11-13
AU728263B2 (en) 2001-01-04
AU2645097A (en) 1997-11-26
AU2644997A (en) 1997-11-12
EP0906333B1 (en) 2001-07-25

Similar Documents

Publication Publication Date Title
ATE203545T1 (de) Substrate und inhibitoren von proteolytischen enzymen
DE69731226D1 (de) Verwendung von substrat-subtraktionsbibliotheken zur unterscheidung von enzymspezifitäten
DE69938766D1 (de) Verfahren zur Rückgewinnung von Substratscheiben
ATA2998A (de) Verfahren und vorrichtung zum ausgerichteten zusammenführen von scheibenförmigen halbleitersubstraten
DE69828682D1 (de) Nanomolare, non-peptidische inhibitoren von cathepsin d
MX9804623A (es) Precursores inactivos de farmacos inhibidores de trombina.
DE69718142D1 (de) Verfahren zum ätzen von halbleiterscheiben
ATE250066T1 (de) Verfahren zur reduktion von oxiranyl-epothilonen zu olefinischen epothilonen
DE60045416D1 (de) Verfahren zur behandlung von mikroelektroniksubstraten
DE69636183D1 (de) Vorrichtung zur Prüfung von Halbleitersubstraten
DE69916035D1 (de) Vorrichtung zur behandlung von halbleiterscheiben
DE69918089D1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
DE69707219D1 (de) Verfahren zum Herstellen von Silizium-Halbleiter Einzelsubstrat
DE69835532D1 (de) Quinolin-enthaltende alpha-ketoamid-basierte inhibitoren von cystein- und serin protease
BR0008625A (pt) Processo para tratamento de asma induzida por exercìcio
AU6458396A (en) Phosphorous-containing cysteine and serine protease inhibitors
DE69431564D1 (de) Reagenz zur behandlung von arthritischen zustaenden
DE69012319D1 (de) Verfahren zur entfernung von beschichtungen empfindlicher substrate und werfmedia dazu.
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
MX9805948A (es) Substratos e inhibidores para proteasa de cisteina ich-1.
WO2004042352A3 (en) Substrates of n-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates
DE69835376D1 (de) Verfahren zum auffinden von verbindungen zur vorbeugung von infektion oder pathogenizität
ATE323173T1 (de) Nährboden zum nachweis und/oder zur unterscheidung von enterokokken
WO2003092719A3 (en) Methods and compositions for modulating beta-catenin phosphorylation
DE60331414D1 (de) Aggrecanase-1- und -2-peptidsubstrate und verfahren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties